The biosimilar market in India is projected to grow at a compound annual growth rate (CAGR) of 18.10% from 2024 to 2032. This growth is driven by the increasing prevalence of chronic diseases such as cancer, autoimmune disorders, and diabetes, leading to a higher demand for biologic drugs. https://www.imarcgroup.com/india-biosimilar-market